Adverts

Open Access Articles- Top Results for ATC-0175

ATC-0175

</th></tr>
ATC-0175
File:ATC-0175 structure.png
Systematic (IUPAC) name
N-[cis-4-([4-(dimethylamino)quinazolin-2-yl]amino)cyclohexyl]-3,4-difluorobenzamide
Clinical data
Identifiers
ChemSpider 8109661 7pxY
Chemical data
Formula C23H25F2N5O
425.473
 14pxY (what is this?)  (verify)

ATC-0175 is a drug used in scientific research, which is a selective, non-peptide antagonist at the melanin concentrating hormone receptor MCH1. In animal studies it has been shown to produce both anxiolytic and antidepressant actions, but without sedative or ataxic side effects.[1][2][3]

References

  1. ^ Chaki S, Funakoshi T, Hirota-Okuno S, Nishiguchi M, Shimazaki T, Iijima M, Grottick AJ, Kanuma K, Omodera K, Sekiguchi Y, Okuyama S, Tran TA, Semple G, Thomsen W (May 2005). "Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists". The Journal of Pharmacology and Experimental Therapeutics 313 (2): 831–9. PMID 15677346. doi:10.1124/jpet.104.081711. 
  2. ^ Kanuma K, Omodera K, Nishiguchi M, Funakoshi T, Chaki S, Semple G, Tran TA, Kramer B, Hsu D, Casper M, Thomsen B, Sekiguchi Y (September 2005). "Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1". Bioorganic & Medicinal Chemistry Letters 15 (17): 3853–6. PMID 16002290. doi:10.1016/j.bmcl.2005.05.121. 
  3. ^ Chaki S, Yamaguchi J, Yamada H, Thomsen W, Tran TA, Semple G, Sekiguchi Y (2005). "ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety". CNS Drug Reviews 11 (4): 341–52. PMID 16614734. doi:10.1111/j.1527-3458.2005.tb00052.x. 

Lua error in package.lua at line 80: module 'Module:Buffer' not found.